Atlas Bio

Round
atlas.bio Biotech & Healthcare
Total Funding $18.5M
Latest Round $12.5M Round
Last Announced Oct 27, 2026
Investors 2 Backers
Decision Makers Profile Active

About Atlas Bio

See which development path to back before you commit. Atlas runs in silico clinical trials in immunology using its foundation AI model of human biology to predict and compare patient responses across treatments and indications, helping biopharma teams decide what to advance, acquire or expand.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Round
Global Headquarters Undisclosed
Tracked Since Oct 27, 2026

Web & Domain Identity

Official Website atlas.bio
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $12,500,000 · Round

    Backed by Creandum

  2. Capital Raise

    Raised $6,000,000 · Seed

    fundraisingfox.com

Investors & Backers

2
Creandum
Lead
LEA Partners

Funding History

2 Rounds
Round equity · Oct 27, 2026

Round backers: Creandum

$12,500,000 tech.eu
Seed equity · Apr 9, 2026

Founders & Leadership

2

Sebastian Bayer

Co-Founder & CTO

Work email & phone locked Unlock →

Simon Romanski

Co-Founder & CEO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts